Supreme Court Upholds Tribunal's Decision on Product Classification — Homeopathic Medicine Recognized. The classification of AHAHO as a medicament was affirmed based on historical acceptance and therapeutic claims.

  • 0
Judgement Image
Font size:
Print

Case Note & Summary

This case involved an appeal against a decision by the Customs, Excise and Service Tax Appellate Tribunal regarding the classification of 'Aswini Homeo Arnica Hair Oil' (AHAHO) for excise duty purposes. The appellant, the Commissioner of Customs, argued that the product should be classified as a cosmetic under Chapter 33 of the Central Excise Tariff Act, 1985, while the respondent, Aswini Homeo Pharmacy, contended it was a medicament under Chapter 30. The Adjudicating Authority had previously classified AHAHO as a medicament but later sought to reclassify it as a cosmetic due to changes in tariff entries and the product's marketing. The Tribunal, however, upheld the original classification as a medicament, citing historical acceptance and the product's therapeutic claims. The court analyzed the product's ingredients, labeling, and common usage, ultimately concluding that AHAHO was recognized as a homeopathic medicine and should not be classified as a cosmetic. The Supreme Court affirmed the Tribunal's decision, emphasizing the importance of consistent classification based on established legal principles and the product's intended use.

Headnote

A) Central Excise - Classification of Goods - Medicament vs Cosmetic - Classification of AHAHO as 'medicament' under Chapter 30 upheld - Central Excise Tariff Act, 1985, Chapter 30, Chapter 33 - The Tribunal found that the product AHAHO, being a homeopathic preparation, was rightly classified as a medicament, rejecting the Adjudicating Authority's view that it was a cosmetic. The Tribunal emphasized the historical acceptance of the product's classification and the lack of substantial changes warranting reclassification (Paras 1.2, 7.5).

Subscribe to unlock Headnote Subscribe Now

Issue of Consideration

Whether the product AHAHO is classified as 'medicament' under Chapter 30 or as 'cosmetic' under Chapter 33 of the First Schedule to the Central Excise Tariff Act, 1985.

Subscribe to unlock Issue of Consideration Subscribe Now

Final Decision

The Supreme Court upheld the Tribunal's decision, affirming that AHAHO was classified as a medicament under Chapter 30 of the Central Excise Tariff Act, 1985, and rejected the reclassification as a cosmetic.

Law Points

  • Classification of goods
  • Central Excise Tariff
  • Medicament vs Cosmetic
  • Show Cause Notice
  • Adjudicating Authority
  • Tribunal's authority
Subscribe to unlock Law Points Subscribe Now

Case Details

2023 LawText (SC) (05) 200

Civil Appeal No. 9525 of 2018

2018-01-31

Dinesh Maheshwari

Commissioner of Customs, Central Excise and Service Tax, Hyderabad

Ashwani Homeo Pharmacy

Subscribe to unlock Case Details (Citation, Judge, Date & more) Subscribe Now

Nature of Litigation

Dispute over classification of a product for excise duty purposes.

Remedy Sought

The appellant sought to maintain the classification of AHAHO as a cosmetic and uphold the demand for differential duty.

Filing Reason

The respondent challenged the reclassification of AHAHO from medicament to cosmetic.

Previous Decisions

The product had been classified as a medicament since 1994, with prior acceptance by the Department.

Issues

Whether AHAHO is classified as 'medicament' or 'cosmetic'. Whether the re-examination of classification was justified due to tariff amendments.

Submissions/Arguments

The appellant argued that AHAHO should be classified as a cosmetic based on its marketing and labeling. The respondent contended that AHAHO was a medicament with therapeutic properties, supported by historical classification.

Ratio Decidendi

The classification of goods must be consistent with historical acceptance and the intended use of the product, particularly in the context of therapeutic claims.

Judgment Excerpts

The Tribunal found that the product AHAHO, being a homeopathic preparation, was rightly classified as a medicament. The product clearly mentioned its use for other ailments like sleep loss.

Procedural History

The case began with a show-cause notice issued to the respondent, followed by adjudication by the Commissioner, an appeal to the Tribunal, and ultimately an appeal to the Supreme Court.

Acts & Sections

  • Central Excise Tariff Act, 1985: Chapter 30, Chapter 33
  • Central Excise Act, 1944: Section 11A, Section 11AA
  • Drugs and Cosmetics Act, 1940: Section 97
  • Drugs and Cosmetics Rules, 1945: Schedule K
Subscribe to unlock full Legal Analysis Subscribe Now
Related Judgement
High Court Bombay High Court Dismisses Winding-Up Petition Under Sections 433 and 434 of Companies Act, 1956 — Guarantee Debt Disputed on Grounds of Foreign Law and Lack of Service of Statutory Notice. Court holds that a winding-up petition based on a guarant...
Related Judgement
Supreme Court Supreme Court Disposes of Custody and Habeas Corpus Matters with Directions for Joint Parenting. The Court emphasized the need for shared parenting in the U.S. as the children were U.S. citizens and not ordinarily residing in India under Section 9 of...